Cargando…
Improving the clinical impact of biomaterials in cancer immunotherapy
Immunotherapies for cancer have progressed enormously over the past few decades, and hold great promise for the future. The successes of these therapies, with some patients showing durable and complete remission, demonstrate the power of harnessing the immune system to eradicate tumors. However, the...
Autores principales: | Gammon, Joshua M., Dold, Neil M., Jewell, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4941251/ https://www.ncbi.nlm.nih.gov/pubmed/26871948 http://dx.doi.org/10.18632/oncotarget.7304 |
Ejemplares similares
-
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022) -
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
por: Liu, Yilun, et al.
Publicado: (2021) -
Biomaterials promote in vivo generation and immunotherapy of CAR-T cells
por: Qin, Ya-Ting, et al.
Publicado: (2023) -
Advanced biomaterials for cancer immunotherapy
por: Yang, Fan, et al.
Publicado: (2020) -
Engineered biomaterials for cancer immunotherapy
por: Cai, Lulu, et al.
Publicado: (2020)